Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck
Clinical trial NCT02979977 · COMPLETED
Trial details
- NCT number
- NCT02979977
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-24
- Primary completion
- 2025-01-18
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.